Despite the associated high probability of fetal risks in pregnant patients, mycophenolate remains one of the most commonly used immunosuppressants for patients receiving a solid organ transplant (SOT). To help combat the risks associated with mycophenolate treatment, the ongoing FDA …
Disparities in the diagnosis, treatment, and outcomes of cardiovascular disorders, including hypertension, disproportionately affect underserved racial and ethnic populations as well as the LGBTQIA+ community. These groups face significant barriers, such as lower rates of hypertension control, increased cardiovascular mortality, …
Low health literacy and limited English proficiency (LEP) significantly impact health care access and outcomes for members of diverse racial and ethnic groups, including Asian and Latine individuals. Addressing these barriers is critical for improving health equity and ensuring effective …
Health inequities in the diagnosis, treatment, and outcomes of gastrointestinal disorders significantly impact racial, ethnic, and immigrant populations. Patients born outside the U.S. are less likely to be diagnosed with inflammatory bowel disease (IBD) before age 16 and often face …
Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of biomarkers, current and emerging therapies, and how the latest clinical …
Developmental and epileptic encephalopathies (DEEs) make up a diverse range of conditions that generally present with epileptic seizures and electroencephalogram (EEG) abnormalities. DEEs significantly impact children and adults living with the condition, as well as their caregivers. Patients and caregivers …
Developmental and epileptic encephalopathies (DEEs) make up a diverse range of conditions that generally present with significant epileptic seizures and electroencephalogram (EEG) abnormalities. DEEs can significantly impact children and adults living with the condition, as well as caregivers. Patients within …
Biomarker and molecular testing to help oncologists match patients with the best cancer treatment can be challenging in the community oncology setting and in underserved communities. At present, patients with cancer in racially or ethnicly underserved communities are not receiving …
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune, neuro-muscular condition impacting the myelin that insulates and protects peripheral nerves causing mobility and sensory impairment. Standard therapies for CIPD have been recommended for decades, however, there are many unmet needs related …